Search Results < Yale Center for Clinical Investigation

1576 results

News
In Memoriam: Robert “Bob” S. Sherwin, MD
Robert “Bob” S. Sherwin, MD, the inaugural director of YCCI, passed away on March 31 at Yale-New Haven Hospital after a long illness. He was 80 years old. Dr. Sherwin, a world-renowned academic diabetologist, led YCCI through a remarkable period of growth, and all of those who worked with him will remember his kindness, guidance, and wisdom. Together they mourn the loss of a leader whose inspiring vision will continue to serve as a beacon for the growth of clinical and translation research at Yale, and beyond, for years to come.
12 Apr 2023
News
YCCI Interim Director, Dr. David Coleman, recipient of the 2023 Larry Zaroff Man of Good Conscious Award
New Interim Director of YCCI David Coleman, MD, Research Professor of Medicine, Emeritus Professor, Yale School of Medicine, is a recipient of the 2023 Larry Zaroff Man of Good Conscious Award from the American Medical Women’s Association. The Association presents this award annually to a man who has been a champion and supporter of women in medicine.
5 Mar 2023
News
New Data Reported From Trials of Drug Developed at Yale Pathology to Treat Rare, Often Fatal Neonatal Disorder
Clinical trial data from an enzyme-therapy drug developed at Yale Pathology to treat a rare and often fatal neonatal calcification disorder were recently reported. The drug, INZ-701, was designed and validated in the laboratory of Demetrios Braddock, MD, PhD, Associate Professor of Pathology at Yale School of Medicine.
1 Mar 2023
News
Cracking Peanuts and the Code to Wilson Disease
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.
20 Feb 2023
News
YCCI Funding Opportunities Open for Applications
We are announcing a request for applications for support for several awards: YCCI Scholar Awards and Yale Physician-Scientist Development Awards; Multidisciplinary Post-Doctoral Training Program; Multidisciplinary Pre-Doctoral Training Program.
5 Dec 2022
News
New technology could be game changer for people living with Type 1 diabetes
There's a new high-tech tool that could be a game-changer for people with Type 1 diabetes. Yale Principal Investigator and Associate Professor in Pediatrics (Endocrinology), Jennifer Sherr, discusses the Omnipod 5, which monitors insulin levels through a sensor on the skin, then sends the insulin directly through the patch as needed.
Source: WNYT.com
20 Jun 2022
News
Treating Sarcoidosis With JAK Inhibitor Shows Promise in Clinical Trial
Every patient in a Yale clinical trial of a new treatment for the disfiguring disease sarcoidosis saw improvement to their skin — and more than half showed improvement in affected internal organs.
6 Jun 2022
News
Four Yale Researchers Honored at the 2022 Association for Clinical and Translational Science Awards
The collaboration that advanced the discovery of ketamine as a treatment for depression was among four Yale award winners at the Association for Clinical and Translational Science (ACTS) annual meeting held in Chicago from April 20 through 22.
2 May 2022
News
Yale researchers have a formula for getting in the flow
Yale psychologists have developed a mathematical theory of flow, and argue that it is possible to enhance immersion and engagement in almost any task.
26 Apr 2022
News
Linda Coleman accepts appointment to the Board of Directors, Association for the Accreditation of Human Research Protection Programs
Linda Coleman, JD, the Director of the Yale Human Research Protection Program (HRPP), which assists Yale University in meeting its ethical and regulatory obligations for the protection of human research participants, has accepted an appointment to the Board of Directors of the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
14 Feb 2022
News
Researchers produce a cellular blueprint of chronic lung disease
Yale scientists have created an unprecedented atlas of cells found in lungs with Chronic Obstructive Pulmonary Disease (COPD), offering insights that could lead to new therapies.
26 Jan 2022
News
YCCI’s Tesheia Johnson Appointed to CTSA Steering Committee
The National Center for Advancing Translational Sciences (NCATS) has announced the new members of its Clinical and Translational Science Awards (CTSA) Program steering committee, including Yale School of Medicine Director of Clinical Research and Yale Center for Clinical Investigation (YCCI) Chief Operating Officer Tesheia Johnson, MBA, MHS. The steering committee provides direction to NCATS and the more than 60 CTSA-funded institutions around the country, including Yale.
9 Jan 2022
News
Stress makes life’s clock tick faster. Chilling out slows it down
Yale study findings that stress does indeed make life’s clock tick faster — but that individuals can help manage the effects by strengthening their emotion regulation and self-control.
5 Dec 2021
News
FDA and the School of Medicine collaborate to promote diversity in clinical trials
The FDA Office of Minority Health and Health Equity awarded the Yale School of Medicine a $3 million contract to promote diversity in clinical trials.
Source: Yale Daily News
5 Nov 2021
News
In the fight against COVID-19, antibodies are the best long-term weapon
When it comes to long-lasting protection against COVID-19, antibodies — proteins created by B cells to neutralize invading pathogens — are our biggest allies, a new Yale study shows.
2 Sep 2021
News
Yale doctor on CT’s positivity rate nearing 5%, latest research on Moderna’s vaccine, unvaccinated discouraged from Labor Day travel
Yale Infectious Disease expert, Dr. Onyema Ogbuagu discusses CT’s positivity rate nearing 5%, latest research on Moderna’s vaccine, unvaccinated discouraged from Labor Day travel
Source: WTNH
1 Sep 2021
News
New COVID C.1.2 strain could be highly transmissible, evade vaccines
Yale Medicine's Dr. Richard Martinello discusses the new C.1.2 variant which could be more transmissible than current strains and even evade protection from vaccines.
Source: WTNH
30 Aug 2021
News
Portable MRI Provides Life-saving Information to Doctors Treating Strokes
A new Yale-led study shows that a portable MRI device can help identify intracranial hemorrhages, potentially life-saving information in scenarios where access to sophisticated brain imaging scans is not readily available.
25 Aug 2021
News
Your ZIP Code May Be a Factor in How Long You’ll Stay Active
Older people living in less advantaged neighborhoods become disabled roughly two years earlier than their counterparts in more affluent neighborhoods, according to a new Yale study.
23 Aug 2021
News
Preventing Type 1 Diabetes: Q&A With Kevan Herold, MD
Kevan Herold, MD, chair of the international research network Type 1 Diabetes (T1D) TrialNet, hopes to apply lessons from immunobiology to type 1 diabetes in a way that improves human health.
19 Aug 2021